Bisphosphonates and Bone Metastases
Author Information
Author(s): A.R. Morton, A. Howell
Primary Institution: Hope Hospital and Christie Hospital
Conclusion
Bisphosphonates are effective in managing hypercalcaemia caused by malignancy and may help reduce bone pain and the incidence of skeletal metastases.
Supporting Evidence
- A single infusion of 30mg APD restored normal calcium levels in 12 out of 16 patients.
- A single infusion of 60mg APD was as effective as multiple lower doses in restoring normocalcaemia.
- Normocalcaemia persisted longer in patients receiving higher doses of APD.
Takeaway
Bisphosphonates are medicines that help people with cancer by lowering high calcium levels in their blood and can also help with bone pain.
Methodology
The editorial discusses various studies on the effects of bisphosphonates in treating hypercalcaemia and bone metastases.
Potential Biases
There may be a risk of bias due to the subjective nature of pain assessment and the influence of placebo effects.
Limitations
The studies mentioned have limitations such as small sample sizes and potential placebo effects.
Participant Demographics
Patients with carcinoma of the breast and multiple myeloma were included in the studies discussed.
Want to read the original?
Access the complete publication on the publisher's website